Table 3 Distribution of the proportion of participants with abnormal serum follicle-stimulating hormone, luteinizing hormone and anti-mullerian hormone levels by age
Age (years) | FSH | LH | AMH | ||||||
|---|---|---|---|---|---|---|---|---|---|
Reference range (IU/L) | Abnormality | Reference range (IU/L) | Abnormality | Reference range (IU/L) | Abnormality | ||||
Low n(%) | High n(%) | Low n(%) | High n(%) | Low n(%) | High n(%) | ||||
10–12 (n = 11) | 0.7–8.3 | 0(0.0) | 0(0.0) | 0.0-6.8 | 0(0.0) | 2(18.1) | < 8.8 | 0(0.0) | 0(0.0) |
13–15 (n = 45) | 1.0-9.1 | 3(6.7) | 5(11.1) | 0.3–23.0 | 4(8.9) | 4(8.9) | 0.9–9.5 | 0(0.0) | 0(0.0) |
16–17 (n = 16) | 0.4–9.9 | 0(0.0) | 3(17.7) | 0.0-26.4 | 0(0.0) | 2(11.8) | 0.9–9.5 | 0(0.0) | 0(0.0) |
>=18 (n = 29) | 1.7–21.5 | 1(3.5) | 0(0.0) | 1.0-95.6 | 4(13.8) | 0(0.0) | 0.9–9.5 | 0(0.0) | 7(24.1) |